These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 19273537)

  • 1. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and proteomics in predicting cancer outcomes.
    Parikh AA; Johnson JC; Merchant NB
    Surg Oncol Clin N Am; 2008 Apr; 17(2):257-77, vii. PubMed ID: 18375352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is gene expression profiling of head and neck cancers ready for the clinic?
    Ziober AF; D'Alessandro L; Ziober BL
    Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
    Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of cancer--opportunities, challenges, and context.
    Arnott D; Emmert-Buck MR
    J Pathol; 2010 Sep; 222(1):16-20. PubMed ID: 20623483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer: proteomic advances and biomarker achievements.
    Rezende TM; de Souza Freire M; Franco OL
    Cancer; 2010 Nov; 116(21):4914-25. PubMed ID: 20665484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics: clinical applications for head and neck squamous cell carcinoma.
    Yarbrough WG; Slebos RJ; Liebler D
    Head Neck; 2006 Jun; 28(6):549-58. PubMed ID: 16475197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stem cell hypothesis in head and neck cancer.
    Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
    J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based "omics" technologies in cancer diagnostics.
    Zhang X; Wei D; Yap Y; Li L; Guo S; Chen F
    Mass Spectrom Rev; 2007; 26(3):403-31. PubMed ID: 17405143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecular diagnostic methods in head and neck cancer.
    Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
    Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.